Glutamine modulates CD8αα+ TCRαβ+ intestinal intraepithelial lymphocyte expression in mice with polymicrobial sepsis

Nutrition

Volumn 29, Issue 6, 2013, Pages 911-917

  Tung, Jai Nien ^a   Lee, Wan Yun ^b   Pai, Man Hui ^b   Chen, Wei Jao ^c   Yeh, Chiu Li ^d   Yeh, Sung Ling ^b  

^a TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHINESE CULTURE UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; CD8 + TCR + IELs; Glutamine; Intraepithelial lymphocytes; Sepsis

Indexed keywords

CD8ALPHA ANTIGEN; COMPLEMENT COMPONENT C5A RECEPTOR; GAMMA INTERFERON; GLUTAMINE; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BCL XL; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DOWN REGULATION; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; IMMUNOMODULATION; INTRAEPITHELIAL LYMPHOCYTE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLYMICROBIAL SEPSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SINGLE DRUG DOSE;

ANIMALS; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL2; DOWN-REGULATION; EPITHELIAL CELLS; GENE EXPRESSION; GLUTAMINE; INTERFERON-GAMMA; INTERLEUKIN-15 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, INTERLEUKIN-7; RNA, MESSENGER; SEPSIS;

MUS;

EID: 84877631757     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.01.001     Document Type: Article

References (32)

1. Cheroutre H., Lambolez F., Mucida D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol 2011, 11:445-456.
2. Camerini V., Panwala C., Kronenberg M. Regional specialization of the mucosal immune system. Intraepithelial lymphocytes of the large intestine have a different phenotype and function than those of the small intestine. J Immunol 1993, 151:1765-1776.
3. + intestinal intraepithelial lymphocytes by TGF-β. Nat Immunol 2011, 12:312-319.
4. Saurer L., Seibold I., Rihs S., Vallan C., Dumrese T., Mueller C. Virus-induced activation of self-specific tcr alpha beta CD8 aplha alpha intraepithelial lymphocytes does not abolish their self-tolerance in the intestine. J Immunol 2004, 172:4176-4183.
5. Gardiner K., Barbul A. Intestinal amino acid absorption during sepsis. J Parenter Enteral Nutr 1993, 17:277-283.
6. Chung C.S., Watkins L., Funches A., Lomas-Neira J., Cioffi W.G., Ayala A. Deficiency of gammadelta T lymphocytes contributes to mortality and immunosuppression in sepsis. Am J Physiol Regul Integr Comp Physiol 2006, 291:R1338-R1343.
7. Wischmeyer P.E. Glutamine: Role in critical illness and ongoing clinical trials. Curr Opin Gastroenterol 2008, 24:190-197.
8. Goeters C., Wenn A., Mertes N., Wempe C., Van Aken H., Stehle P., et al. Parenteral l-alanyl-l-glutamine improves 6-month outcome in critically ill patients. Crit Care Med 2002, 30:2032-2037.
9. Houdijk A.P., Rijnsburger E.R., Jansen J., Wesdorp R.I., Weiss J.K., McCamish M.A., et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998, 352:772-776.
10. Wilmore D.W., Shabert J.K. Role of glutamine in immunologic responses. Nutrition 1998, 14:618-626.
11. Lacey J.M., Wilmore D.W. Is glutamine a conditionally essential amino acid?. Nutr Rev 1990, 48:297-309.
12. Nose K., Yang H., Sun X., Nose S., Koga H., Feng Y., et al. Glutamine prevents total parenteral nutrition-associated changes to intraepithelial lymphocyte phenotype and function: A potential mechanism for the preservation of epithelial barrier function. J Interferon Cytokine Res 2010, 30:67-80.
13. Ayala A., Deol Z.K., Lehman D.L., Herdon C.D., Chaudry I.H. Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production. J Surg Res 1994, 56:579-585.
14. Wichterman K.A., Baue A.E., Chaudry I.H. Sepsis and septic shock-a review of laboratory models and a proposal. J Surg Res 1980, 29:189-201.
15. Chennupati V., Worbs T., Liu X., Malinarich F.H., Schmitz S., Haas J.D., et al. Intra- and intercompartmental movement of gammadelta T cells: Intestinal intraepithelial and peripheral gammadelta T cells represent exclusive nonoverlapping populations with distinct migration characteristics. J Immunol 2010, 185:5160-5168.
16. Waldmann T.A. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 2006, 6:595-601.
17. Taniguchi T., Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell 1993, 73:5-8.
18. Kaneko M., Mizunuma T., Takimoto H., Kumazawa Y. Development of tcr alpha beta cd8 alpha alpha intestinal intraepithelial lymphocytes is promoted by interleukin-15-producing epithelial cells constitutively stimulated by gram-negative bacteria via TLR4. Biol Pharm Bull 2004, 27:883-889.
19. Ma L.J., Acero L.F., Zal T., Schluns K.S. Trans-presentation of IL-15 by intestinal epithelial cells drives development of CD8alphaalpha IELs. J Immunol 2009, 183:1044-1054.
20. Porter B.O., Malek T.R. IL-2R beta/IL-7R alpha doubly deficient mice recapitulate the thymic and intraepithelial lymphocyte (iel) developmental defects of gammac-/- mice: Roles for both il-2 and il-15 in cd8alphaalpha iel development. J Immunol 1999, 163:5906-5912.
21. Waldmann T.A. Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases. Arthritis Res Ther 2004, 6:174-177.
22. Peng Q., Li K., Wang N., Li Q., Asgari E., Lu B., et al. Dendritic cell function in allostimulation is modulated by c5ar signaling. J Immunol 2009, 183:6058-6068.
23. Wenderfer S.E., Ke B., Hollmann T.J., Wetsel R.A., Lan H.Y., Braun M.C. C5a receptor deficiency attenuates t cell function and renal disease in mrllpr mice. J Am Soc Nephrol 2005, 16:3572-3582.
24. Tilahun A.Y., Holz M., Wu T.T., David C.S., Rajagopalan G. Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome. PLoS One 2011, 6:e16764.
25. Nussler N.C., Stange B., Nussler A.K., Settmacher U., Langrehr J.M., Neuhaus P., et al. Upregulation of intraepithelial lymphocyte (IEL) function in the small intestinal mucosa in sepsis. Shock 2001, 16:454-458.
26. Le Tulzo Y., Pangault C., Gacouin A., Guilloux V., Tribut O., Amiot L., et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 2002, 18:487-494.
27. + lymphocytes. J Immunol 2000, 165:1743-1754.
28. Evans M.E., Jones D.P., Ziegler T.R. Glutamine inhibits cytokine-induced apoptosis in human colonic epithelial cells via the pyrimidine pathway. Am J Physiol Gastrointest Liver Physiol 2005, 289:G388-G396.
29. Sukhotnik I., Agam M., Shamir R., Shehadeh N., Lurie M., Coran A.G., et al. Oral glutamine prevents gut mucosal injury and improves mucosal recovery following lipopolysaccharide endotoxemia in a rat. J Surg Res 2007, 143:379-384.
30. Maki K., Sunaga S., Komagata Y., Kodaira Y., Mabuchi A., Karasuyama H., et al. Interleukin 7 receptor-deficient mice lack gammadelta t cells. Proc Natl Acad Sci U S A 1996, 93:7172-7177.
31. Wischmeyer P.E. Glutamine: mode of action in critical illness. Crit Care Med 2007, 35:S541-S544.
32. Welbourne T.C. Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney. Can J Biochem 1979, 57:233-237.